Skip to content
- July 9, 2015
- FDA Grants Fast Track Designation to Tocagen’s Toca 511 & Toca FC for Treatment of Recurrent High Grade Glioma
- June 17, 2015
- Tocagen Appoints Asha Das, M.D, as Vice President Clinical Development and Medical Affairs
- May 5, 2015
- Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors
- May 4, 2015
- Tocagen Announces Updates from FDA Meeting and Clinical Data Presentations at AANS/CNS
- April 30, 2015
- Tocagen Announces Presentations at the AANS/CNS Joint Section on Tumors
- February 25, 2015
- Tocagen Appoints Paul Schimmel, Ph.D, to the Board of Directors
- December 2, 2014
- Tocagen Appoints Franklin M. Berger, CFA, to the Board of Directors
- November 18, 2014
- Toca 511 & Toca FC Survival and PFS-6 Data Surpasses Published Benchmarks
- November 14, 2014
- Tocagen Appoints Faheem Hasnain as Chairman of the Board of Directors
- November 11, 2014
- Tocagen Announces Presentations at SNO 2014 Annual Conference
- August 26, 2014
- Tocagen Expands Clinical Development Team; Names Wayne Saville, M.D., Vice President, Clinical Development, and Mary Rose Keller Vice President, Clinical Operations
- May 22, 2014
- Tocagen announces presentations at ASGCT and ASCO annual conferences
- April 10, 2014
- Tocagen Clinical Data Presented at AANS Annual Conference
- March 25, 2014
- Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
- March 11, 2014
- Tocagen Announces Dosing of First Patient In Intravenous Study
- November 26, 2013
- Tocagen Announces Data Presentations at SNO conference
- August 6, 2013
- Southern California’s First Real-Time MRI-Guided Gene Therapy for Brain Cancer at UC San Diego Health System
- June 19, 2013
- VABC Awards Grant to Tocagen
- May 30, 2013
- Advancing Neuroscience: MRI Interventions, IMRIS and Tocagen Combine Technologies to Precisely Deliver Potential Cancer-Fighting Drug to Brain Tumors
- July 17, 2012
- Musella Foundation Awards Grant to Tocagen
- February 7, 2012
- Tocagen Forms Diagnostics Partnership with Siemens
- February 3, 2012
- Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
- June 7, 2011
- Tocagen Announces First-in-Human Clinical Trial in Brain Cancer
- May 10, 2011
- American Brain Tumor Association Awards Clinical Research Grant to Tocagen
- August 5, 2010
- NBTS Awards Research Grant for GBM Brain Cancer to Tocagen
- October 26, 2009
- Accelerate Brain Cancer Cure (ABC2) Awards Grant to Tocagen Inc.
